期刊文献+

三种促排卵方法治疗多囊卵巢综合征不孕症的分析 被引量:1

原文传递
导出
摘要 目的比较不同的促排卵方法治疗多囊卵巢综合征(PCOS)不孕症患者的疗效。方法对本院诊断为PCOS不孕症患者65例,共197个周期,按用药不同分为3组,克罗米酚(CC)组21例,患者正常月经或黄体酮撤血后第3天开始服用克罗米酚150mg/d,连续用3d;CC联合人绝经期促性腺激素(HMG)组23例,患者月经第5—9天1:2服CCl00mg/d,月经第9天开始注射HMG37.5—150U/d;HMG组21例,患者月经第5天开始注射HMG37.5—150U/d。CC联合HMG组及HMG组使用HMG的用量及天数随B超提示卵泡的数目及大小随时调整,至注射人绒毛膜促性腺激素(HCG)日停止。结果CC组周期排卵率59%,妊娠率19%,OHSS发生率0;CC联合HMG组周期排卵率81%,妊娠率52.2%,卵巢过度刺激综合征(OHSS)发生率4.3%;HMG组周期排卵率88%,妊娠率57.1%,OHSS发生率33.3%。结论CC联合HMG促排卵是一种安全、疗效确切、费用合理的治疗方案。
作者 于艳松
出处 《中国医师杂志》 CAS 2008年第5期692-693,共2页 Journal of Chinese Physician
  • 相关文献

参考文献5

  • 1The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycysdc ovary syudrome. Fertil Steri1,2004,81 (1) :19-25.
  • 2于传鑫,李诵弦.实用妇科内分泌学.2版.上海:上海医科大学出版社,2006:437-446.
  • 3曹泽毅.中华妇产科学.2版.北京:人民卫生出版社,2005:230-238.
  • 4Tulandi T, Alan H. Limiting access to letrozole-is it justified? . Fertil Steril,2006,86 ( 5 ) : 1447-1450.
  • 5蔺莉,魏丽惠.卵巢过度刺激综合征发生机制的研究进展[J].生殖与避孕,2005,25(2):103-106. 被引量:6

二级参考文献23

  • 1Blank ML, Snyder F, Byers LW, et al. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.Biocherm Biophys Res Commun, 1979, 90(4):1 194-200.
  • 2Ujioka T, Matsuura K, Kawano T. et al. Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod, 1997,12(8):1 629-34.
  • 3Abramov Y, Borak JG & Lewin A. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrom.Hum Reprod, 1996,11(7):1 381-6.
  • 4Tiemann U, Tomek W, Schneider K, et al. Platelet-activating factor (PAF)-activity, localization of PAF receptor(PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. Prostaglandins & Other Lip Med, 2001,65:125-41.
  • 5Geva E, Lessing JB, Lener GL, et al. Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte tetrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome. Fertil Steril, 1997,68(1): 133-7.
  • 6Abramov Y, Schenker JG, Lewin A, et al. Plasma inflammstory cytokine correlate to the ovarian hyperstimulation syndrome.Hum Reprod, 1996, 11(7): 1 381-6.
  • 7Manolopoulos K, Lang U, Gips H, et al. Elevated interleukin10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol, 2001,99(2): 226-31.
  • 8Mathur R, Hayman G, Bansal A, et al. Serum vascular endothelial growth facor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertil Steril,2002,78(6): 1 154-8.
  • 9Ludwig M, Jelkmann W, Bauer O, et al. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod, 1999,14(10): 2 437-41.
  • 10Albert C, Garrido N, Mercader A, et al.The role of endothelial cells in the pathogeneses of ovarian hyperstimulation syndrome. Mol Hum Reprod, 2002,8(5) 409-18.

共引文献8

同被引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部